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ABSTRACT | Objective: this study assessed the influence 
of pre-operative body mass index (BMI) has upon 
lymphedema, scar tissue adhesion, pain, and heaviness 
in the upper limb at two years after surgery for breast 
cancer. Methods: retrospective analysis of 631 medical 
records of women who underwent surgery for breast 
cancer and were referred to the Physiotherapy Program 
at Prof. Dr. José Aristodemo Pinotti Women’s Hospital 
of the Center for Integral Women’s Health Care, CAISM/
UNICAMP between January 2006 and December 2007. 
Results: mean age of women was 56.5 years (±13.7 years) 
and the most part (55%) were overweight or obese, 
surgical stages II and III were present in 63% of women 
studied. Radical mastectomy was the most frequent 
surgery (54.4%), followed by quadrantectomy (32.1%). 
In the first year after surgery, there was no significant 
association between BMI categories and incidence of scar 
tissue adhesion, pain, heaviness and lymphedema. In the 
second year, overweight and obese women had higher 
rates of heaviness in the upper limb and lymphedema. 
For lymphedema, there was a significant difference 
among BMI categories (p=0.0268). Obese women are 3.6 
times more likely to develop lymphedema in the second 
year after surgery (odds ratio 3.61 95% CI 1.36 to 9.41). 
Conclusion: BMI ≥25kg/m2 prior to treatment for breast 
cancer can be considered a risk factor for developing 
lymphedema in the two years after surgery. There was no 
association between BMI and the development of other 
complications.
Keywords: Breast Neoplasms/complications; Lymphedema; 
Body Mass Index; Risk Factors.
RESUMO | Avaliou-se a influência do índice de massa 
corporal (IMC) pré-operatória na ocorrência de linfedema, 
aderência cicatricial, dor e peso no membro superior nos 
primeiros dois anos após cirurgia para câncer de mama. 
O estudo é uma análise retrospectiva, secundária de 631 
prontuários de mulheres submetidas à cirurgia para câncer 
de mama e encaminhadas ao Programa de Fisioterapia do 
Hospital Professor Dr. José Aristodemo Pinotti do Centro 
de Atenção Integral à Saúde da Mulher, CAISM /UNICAMP, 
entre janeiro de 2006 e dezembro de 2007. Eram 
mulheres com idade média de 56,5 anos (±13,7 anos), 
a maioria (55%) com sobrepeso ou obesa. Os estádios 
clínicos II e III foram encontrados em 63% das mulheres. 
Mastectomia radical foi a cirurgia mais frequente (54,4%), 
seguida por quadrantectomia (32,1%). No primeiro ano 
após a cirurgia não houve associação significativa entre 
as categorias do índice de massa corporal e incidência de 
aderência cicatricial, dor, peso e linfedema. No segundo 
ano, mulheres com sobrepeso e obesidade apresentaram 
maiores taxas de peso no membro superior e linfedema. 
Para linfedema houve diferença significativa entre as 
categorias de índice de massa corporal (p=0,0268). 
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Mulheres obesas têm 3,6 vezes mais chance de desenvolver 
linfedema no segundo ano após a cirurgia (odds ratio 3,61 95% IC 
1,36-9,41). Concluiu-se que IMC ≥25kg/m2 anterior ao tratamento 
para câncer de mama pode ser considerado fator de risco para 
desenvolvimento do linfedema dois anos após a cirurgia. Não 
houve associação entre IMC e outras complicações. 
Descritores: Neoplasias da Mama/complicações; Linfedema; 
Índice de Massa Corporal; Fator de Risco.
RESUMEN | Evaluación la influencia del índice de masa 
corporal preoperatorio, la aparición de linfedema, la adhesión 
de tejido cicatrizal, dolor y pesadez en los dos primeros años 
después de la cirugía para el cáncer de mama. Método: análisis 
retrospectivo de 631 historias clínicas de mujeres sometidas a 
cirugía para el cáncer de mama y encaminadas al Programa 
de Fisioterapia do Centro de Atención Integral de la Salud de 
la Mujer – Professor Dr. José Aristodemo Pinotti – CAISM /
UNICAMP entre enero de 2006 y diciembre de 2007. Resultados: 
mujeres de mediana edad 56,5 años (±13,7 años), 55% tenían 
sobrepeso u obesidad. Etapas II y III del cáncer se encontraron 
en el 63% de las mujeres. Cirugía de mastectomía radical fue la 
más frecuente (54,4%), seguido de cuadrantectomía (32,1%). 
En el primer año después de la cirugía no hubo asociación 
significativa entre categorías de índice de masa corporal y 
incidencia de la adhesión del tejido de cicatriz, dolor, peso y 
linfedema. En el segundo año, sobrepeso y obesidad tenían 
mayores tasas de peso y linfedema. Para linfedema hubo 
diferencias significativas entre categorías de índice de masa 
corporal (p=0,0268). Las mujeres obesas tienen 3,6 veces más 
probabilidades de desarrollar linfedema en el segundo año 
después de la cirugía (odds ratio 3,61 IC del 95%: 1,36 a 9,41). 
La conclusión és índice de masa corporal ≥25kg/m2 antes del 
tratamiento para el cáncer de mama puede ser considerado 
un factor de riesgo para desarrollo de linfedema, dos años 
después de la cirugía. No hubo asociación entre el índice de 
masa corporal y otras complicaciones.
Palabras clave: Neoplasias de la Mama/complicaciones, 
Linfedema; Índice de Masa Corporal; Factores de Riesgo.
INTRODUCTION 
Breast cancer is the most common cancer among 
women, with higher incidence in women between 50 
and 60 years of age1. Early diagnosis, technological 
advances, more conservative surgery and new treatment 
modalities have increased the life expectancy of women 
with breast cancer. This improvement in life expectancy 
is contrasted with its impact on overall health, as breast 
cancer and its treatment can have a negative impact on 
women’s lives2.
Breast alteration and arm disorders lead to lower 
quality of life3. Among the complications associated 
with breast cancer treatment, lymphedema is one of 
the most significant, with prevalence rates between 0 
and 56%, which may increase over time4,5. Diversity of 
diagnostic methods and follow-up time explain its wide 
range of occurrence.
Lymphedema is a chronic condition caused by 
the accumulation of protein-rich fluid in interstitial 
spaces. The diagnosis varies depending on the degree of 
limb swelling and other clinical signs and symptoms6. 
Although three quarters of women have symptoms 
within one to two years after surgery, onset may be 
insidious and risk is present for the rest of their lives7. 
Presently, there is no cure for lymphedema; as such, 
the identification of possible risk factors for this 
complication is paramount8.
Studies suggest that potential risk factors for 
developing lymphedema include radiation therapy, 
infection, axillary dissection, type of surgery, the number 
of lymph nodes removed and involved, and obesity. 
Even though it is not known whether these factors 
affect the severity of lymphedema6, obesity can be 
associated with increased chronic inflammation, fibrosis 
and adipose deposition9, therefore obese or overweight 
women are at higher risk for lymphedema. The purpose 
of this study was to investigate the influence of BMI of 
women who underwent survey with axillary dissection 
for breast cancer on the occurrence of lymphedema and 
other complications such as scar tissue adhesion, pain, 
and heaviness in the upper limb within two years after 
surgery.
METHODOLOGY 
We performed a retrospective secondary analysis 
of the medical records of 707 women who underwent 
surgery for breast cancer and who were referred to the 
Physiotherapy Program of Prof. Dr. José Aristodemo 
Pinotti Women’s Hospital of the Integral Healthcare 
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Center, CAISM/UNICAMP between January 2006 
and December 2007.
The original study was approved by the Research 
Ethics Committee of the School of Medicine of 
UNICAMP (no. 1096/2009). As this study employed 
medical record review, it was exempted from the 
requirements of patient consent. 
To analyse the relationship between pre-operative 
BMI and postoperative complications, 631 medical 
records that had data on weight and height, enabled the 
calculation of BMI. These data were collected before 
surgery.
Women were classified according to BMI 
categories of the World Health Organization (WHO): 
underweight (<18.5 kg/m²), normal range (≥18.5 and 
≤24.9 kg/m²), overweight (≥25 and ≤29.9 kg/m²) and 
obese (≥30kg/m²)10.
The postoperative complications analyzed were: 
dehiscence and scar tissue adhesion, pain (located in the 
arm, axilla or breast region), sensation of heaviness in the 
upper limb (UL) and lymphedema. The techniques used 
to identify scar defects were inspection and palpation, 
while arm circumference11 and palpation were used to 
identify lymphedema. Women’s complaints of pain and 
heaviness in the UL were included in medical records.
Information about complications were collected 
from medical records at three time points after surgery: 
we sought information about dehiscence and scar tissue 
adhesion at the end of the fourth week, and information 
about adherence, pain and heaviness in the UL, as well as 
lymphedema in the first and second years after surgery.
A descriptive analysis was performed using 
means, standard deviation, and absolute and relative 
frequencies (% n) for epidemiological and clinical 
characteristics and for the presence of complications. 
To evaluate the association between BMI and 
postoperative complications, chi-square and Fisher 
exact tests were performed. p<0.05 was considered 
statistically significant and for variables with significant 
associations, odds ratios were calculated to assess the 
magnitude of association.
REHABILITATION PROGRAM
On the first day after surgery, a physical therapist 
guides women to perform three upper body exercises: 
flexion, abduction and shoulder rotation. At hospital 
discharge, women received a booklet with guidelines 
about care of the ipsilateral arm and instructions to 
perform the exercises at home. The women received 
also the referral to the Rehabilitation Program, which 
has multidisciplinary team (physical therapist, nurse, 
psychologist and social assistant). On the first month 
after the surgery, women performed active group 
exercises (constituted approximately 19 exercises for the 
upper limb, containing stretching, active exercise and 
relaxation)12, three times a week, lasting about an hour. 
At the end of the program, women are evaluated by a 
physical therapist and stimulated to nurse the ipsilateral 
upper limb.
RESULTS
Among the 707 medical records consulted, 
513 (72.6%) were from patients that joined the 
Rehabilitation Program and 76 were excluded because 
they lacked weight and height data used to calculate 
BMI before surgery. Among the other 631 women, 36 
were underweight, 206 were normal range, 213 were 
overweight and 176 were obese. Throughout the first and 
second years after surgery, occurred a reduction in follow 
up visits and outpatient physical therapy (Figure 1).
The mean age of women was 56.5 years (±13.7 years). 
The mean BMI (27.32 kg/m²) was considered above 
normal range, most women (55%) were overweight or 
obese (BMI>25 kg/m²) and sixty-three percent (63%) of 
women had surgical stage II and III. The most frequent 
surgery was radical mastectomy (54.4%), followed by 
quadrantectomy (32.1%) (Table 1).
The complications of dehiscence and scar tissue 
adhesion at the end of the fourth week after surgery were 
not significantly associated with any of the categories of 
preoperative BMI (Table 2).
During the first year after surgery, there were no 
significant differences between BMI categories and the 
frequency of scar tissue adhesion, pain, heaviness and 
lymphedema (Table 3).
There was no significant association between BMI 
categories and pain, scar tissue adhesion or heaviness in 
the upper limb, although in the second year after surgery 
the occurrence was lower in women with greater BMI. 
We observed that only the development of lymphedema 
had significant differences among categories of BMI 
(p=0.0268) (Table 4). Almost 40% of obese women 
who returned to follow up in the second year after 
surgery developed lymphedema (Table 4). Analysing 
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this complication, we found that obese women are 3.6 
times more likely to develop lymphedema in the second 
year after surgery (OR 3.61 95% CI 1.36 to 9.41) (data 
not shown in table).
Charts/Medical Records
N = 707
Unknown BMI
N = 76
Knwon BMI
N = 631
Underweight
N = 36
N = 204 weeks
1st year
2nd year
N = 20
N = 6
N = 153
N = 140
N = 61
N = 157
N = 141
N = 49
N = 140
N = 114
N = 39
N. weight
N = 206
Overweight
N = 213
Obese
N = 176
Figure 1. Number of medical records in the first two years after surgery for breast cancer
Table 1. Surgical and epidemiological characteristics of women
Variables
 N total = 707
N Mean SD (%)
Age 56.5 13.7
Weight 67.85 13.86
Height 1.58 0.07
BMI 27.32 5.2
underweight 36 (5.1)
normal range 206 (29.1)
overweight 213 (30.1)
obese 176 (24.9)
unknown 76 (10.7)
Clinical Stage
is – I 228 (32.2)
II – III 445 (62.9)
IV 22 (3.1)
unknown 12 (1.7)
Surgeries
margin ampliation 5 (0.7)
quadrantectomy + SLB 121 (17.1)
quadrantectomy + AD 106 (15)
M + SLB 46 (6.5)
SM 31 (4.3)
SM + AD 13 (1.8)
MMRM 186 (26.3)
PMRM 189 (26.7)
HRM 10     (1.4)
BMI: body mass index; Is: in situ; M: mastectomy; SLB: sentinel lymphonode biopsy; SMS: simple mastectomy; AD: axillary dissection; MMRM: Madden modified radical mastectomy; PMRP: Patey 
modified radical mastectomy; HRM: Halsted radical mastectomy
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Table 2. Complications according to BMI categories after 4 weeks of surgery
  Under weight Normal range Overweight Obese p value
n=20 (%) n=153 (%) n=157 (%) n=140 (%)  
Dehiscence 3 (15) 29 (18.8) 40 (25.5) 34 (24.3) 0.4093
Adhesion 6 (30) 55 (35.7) 58 (36.9) 43 (30.7) 0.6634
Chi-square test
Table 3. Complications according to BMI categories in the 1st year after surgery
Under weight Normal range Overweight Obese p value
n=20 (%) n=140 (%) n=141 (%) n=114 (%)  
Adhesion 3 (15) 15 (10.7) 11 (7.8) 15 (13.2) 0.3467
Pain 6 (30) 47 (33.6) 51 (36.2) 36 (31.6) 0.8643
Heaviness 1 (5) 30 (21.4) 32 (22.7) 29 (25.4) 0.2416
Lymphedema 1 (5) 6 (4.3) 9 (6.4) 11 (9.6) 0.3818
Chi-square test
Table 4. Complications according to BMI categories in the second year after surgery
Under weight Normal range Overweight Obese p value
  n=6 (%) n=61 (%) n=49 (%) n=39 (%)  
Adhesion 1 (16.7) 6 (9.8) 6 (12.2) 1 (2.6) 0.2529
Pain 3 (33.3) 32 (52.5) 18 (36.7) 20 (51.3) 0.3031
Heaviness 3 (50) 23 (37.7) 18 (36.7) 22 (56.4) 0.2199
Lymphedema 0 (0) 9 (14.8) 13 (26.5) 15 (38.5) 0.0268
Fisher’s exact test
DISCUSSION
Up to one year after surgery for breast cancer, 
the different categories of BMI were not related 
with increased risk of developing scar tissue or UL 
complications. However, when evaluating women 6 and 
12 months after surgery for breast cancer, Kwan et al 
(2010) observed a predictive relationship between the 
emergence of one or more complications of UL, such as 
pain, lymphedema and functional impairment with loss 
of range of motion, and high BMI5. There are no studies 
in the literature that evaluate the influence of BMI on 
dehiscence, pain and tissue adhesion. 
In the second year after surgery, women either 
overweight or obese had higher rates of lymphedema, 
while the other complications analyzed did not 
correlate with BMI. Among many factors associated 
with the development of lymphedema, surgery and 
radiotherapy are worth mentioning 12. However, women 
who at diagnosis are obese or who gain weight after 
the onset of breast cancer may be at increased risk for 
lymphedema6,8,13-16.
A study observed that women with BMI >30 kg/
m2 had two-times greater risk for lymphedema and 
multivariate analysis revealed that women with this 
category of preoperative BMI had a 2.93 greater chance 
of developing lymphedema compared to those with 
BMI <25 kg/m2 (95% CI 1.03-8.31)7. The same was 
observed in a study of 997 women diagnosed with 
invasive breast cancer, of which 133 had lymphedema 
and were overweight at diagnosis of the disease with 
elevated risk for this complication (hazard ratio, 1.43, 
95% CI, 0.88-2.31)5.
In agreement with the literature, this study 
demonstrated that at the end of the second year, almost 
40% of obese women at follow up visit had lymphedema. 
As for heaviness in the UL reported by the patients, this 
number increased to 56%.
It is not completely clear whether increased BMI is 
a direct risk factor for the development of lymphedema 
and two possible explanations for the observed influence 
of obesity on the development of lymphedema are: (a) in 
survivors of breast cancer with damage to the lymphatic 
system, the additional demand created by increasing 
body fat mass causes an imbalance between the volume 
of fluid and the lymphatic transport capacity5,8,17; and 
(b) increased endocrine response, that is, increased 
secretion of peptides, may contribute to lymphedema 
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and tissue inflammation of the limbs of women at risk18. 
Surgery may also need to be more extensive as a result 
of the presence of adipose tissue and therefore more 
destructive to the lymphatic system8.
Obesity may not be a direct risk factor for developing 
lymphedema, but may be a risk for infections, scarring 
disorders (delayed healing, seroma, and fat necrosis), 
lymphangitis and lymphatic obstruction19. According 
to Ahemed et al. (2011) diseases that affect circulation 
such as coronary artery disease, hypertension or diabetes 
mellitus may increase lymphedema or symptoms in the 
upper limbs. However, after adjustment for obesity, 
there are no associations individually or collectively 
with these comorbidities6.
There is little information about the determinants 
of lymph flow, and thus further studies on lymphatic 
drainage and impedance should be performed to 
accurately determine the precise pathogenesis of 
lymphedema in obesity7.
The diagnosis of advanced cancer seems to have an 
influence on the onset of lymphedema. It was observed 
in this study that more than 60% of women studied 
presented an advanced stage of cancer and lymphedema, 
a result consistent with literature. In prospective 
cohort study of 1287 women, 104 (8%) developed 
lymphedema, 475 (37%) presented arm symptoms 
without a diagnosis of lymphedema and 708 (55%) 
did not present lymphedema. It was observed that in 
addition to the signs of more advanced cancer (locally 
advanced or nodal didease) and their treatment (greater 
number of lymph nodes removed and chemotherapy), 
there are modifiable characteristics associated with 
behaviours that increased risk of lymphedema and 
related symptoms, in particular, obesity and poor 
general health status6.
Hayes et al. (2008) point out that a sedentary lifestyle 
(OR, 1.9, 95% CI, 0.6-5.5) is associated with higher 
risk of lymphedema20, on the other hand several studies 
point out that signs and symptoms did not increase 
with exercise21. Therefore, it is safe for women treated 
for breast cancer to engage in physical activity22.
A review on clinical trials concluded that carefully 
controlled physical activity does not alter the risk for 
occurrence or worsen the symptoms of lymphedema 
and may be a strategy to reduce obesity and improve 
women’s overall health and quality of life when treated 
for breast cancer23. 
The following may limit this study: the exclusion 
of 76 records that did not present weight and height 
data to calculate BMI, not all women adhere to the 
Rehabilitation Program, the number of different follow 
up visits, the evaluations made by different physical 
therapists and the retrospectively data collection, which 
made it difficult to obtain data relatied to adjuvant 
treatments.
This study shows that approach to preoperative 
patients with breast cancer should be focused on weight 
control. Moreover, implement strategies for late follow-
up of these women in order to prevent lymphedema. 
CONCLUSION
Women with BMI ≥25kg/m2 prior to surgery 
for breast cancer have a greater risk for developing 
lymphedema in the second year after surgery. The 
incidence of other complications such as pain, tissue 
adhesions, dehiscence, and heaviness in UL were not 
influenced by BMI.
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